Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients
A clinical trial focusing on characterizing circulating and infiltrating immune cells and tumor cells in cancer patients to better understan…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery [NA]
A completed clinical trial investigated whether the gut microbiome can serve as an indicator of readiness for head and neck cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy [Phase 2]
Phase 2 clinical trial evaluating a nutritional supplement containing arginine, omega-3 fatty acids, and nucleotides in patients with Stage …
-
EMA approval · 2025-02-13EMA Authorised: Docetaxel Accord (docetaxel) — Accord Healthcare S.L.U.
The EMA authorised Docetaxel Accord (docetaxel) from Accord Healthcare for multiple cancer indications, including head and neck cancer, non-…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03 [NA]
This clinical trial update reports the completion of the STEREO-POSTOP 01 trial evaluating post-operative hypofractionated stereotactic body…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer [NA]
A clinical trial update indicates that optical surface guidance for external radiotherapy in head and neck cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma [NA]
This trial evaluates simultaneous integrated boost carbon ion radiotherapy for head and neck adenoid cystic carcinoma. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. [NA]
This clinical trial update describes an education intervention aimed at helping patients manage rash associated with epidermal growth factor…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Sarcopenia in Head and Neck Cancer Patients Treated with Curative Hadrontherapy
This clinical trial update reports the completion of a study examining sarcopenia in head and neck cancer patients treated with curative had…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update of LYT-200 as a single agent and in combination with chemotherapy or tislelizumab in locally advanced or met…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Mouth Opening, Prevention, Education, Nutrition (OPEN) [NA]
Update on an ongoing clinical trial focused on mouth opening, prevention, education, and nutrition for patients with trismus and head and ne…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Re-irradiation of Recurrent Head and Neck Cancer
A clinical trial (NCT01973179) from Technische Universität Dresden is evaluating re-irradiation for recurrent head and neck cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer [NA]
A clinical-trial update shows that MucoLox Formulation, designed to mitigate oral mucositis in head and neck cancer patients, has been termi…
-
CLINICAL_TRIALS withdrawal · 2025-02-04Clinical Trial Update: Mood Disorders in Head and Neck Cancer Patients [Phase 4]
Phase 4 clinical trial investigating mood disorders in head and neck cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: On-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software [NA]
Completed clinical trial evaluating on-treatment adaptation of radiotherapy dosimetry for head and neck cancer using novel cone-beam CT and …
-
CLINICAL_TRIALS other · 2025-02-04Clinical Trial Update: Impact of the Oral Microbiota on Relapse in HNSCC Patients [Phase 4]
Phase 4 clinical trial investigating the impact of the oral microbiota on relapse in patients with head and neck cancer, currently active bu…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
Clinical trial update describing the use of predictive tools to guide radiotherapy in head and neck cancer patients. The study is currently …
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Lipiodal Injection Technique for Free Flap Sparing Adjuvant RT Planning in HNC [EARLY_Phase 1]
Phase 1 clinical trial update on Lipiodol injection techniques for sparing free flap surgery in head and neck cancer during adjuvant radioth…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
A clinical trial network in Ontario (MOHCCN-O) is currently recruiting across multiple cancer indications, including breast, colorectal, pan…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Anti-platelet + Pembro for H&N Tumors [Phase 1]
Phase 1 trial testing an anti-platelet agent in combination with Pembrolizumab for head and neck cancer has completed. The update reflects t…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Improving Evidence-Based Care for Cancer Patients
A completed clinical trial sponsored by the Medical University of South Carolina provides updates on evidence-based care for cancer patients…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Ixovex-1 Single Agent and Combination Therapy [Phase 1, Phase 2]
Ixovex-1 is being studied as a single-agent and combination therapy in Phase 1/Phase 2 trials for solid tumors including head and neck cance…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Transdisciplinary Oral/Oropharyngeal Cancer Research & Care in Head and Neck Cancer (TORCH) [NA]
A clinical trial update indicates the TORCH program for transdisciplinary oral/oropharyngeal cancer research and care in head and neck cance…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Adaptive Radiation Treatment for Head and Neck Cancer [Phase 3]
A Phase 3 clinical trial evaluating adaptive radiation treatment for head and neck cancer sponsored by The Netherlands Cancer Institute has …
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer
Ongoing clinical trial evaluating how mutant p53 and YAP proteins contribute to therapy resistance in recurrent head and neck cancer; curren…